Dr. Abdelhakim Al-Alawi: EU Court Ruling Overturns Titanium Dioxide Cancer Classification: Major Regulatory Implications

International Environmental Enforcement Expert at the World Customs Organization and the United Nations Environment Programme

EU Court of Justice Ruling on Titanium Dioxide (TiO₂): Regulatory, Trade, and Health Implications
(Analytical Review)

1. Background

The Court of Justice of the European Union (CJEU) has issued a final ruling annulling the European Union’s 2020 classification of titanium dioxide (TiO₂) in certain powder forms as a substance “suspected of causing cancer by inhalation.”

This ruling marks a significant milestone ina the regulation of chemicals within the EU, given the substance’s substantial economic importance and its widespread use in industries such as paints, plastics, paper, inks, cosmetics, and other industrial applications.

2. What is Titanium Dioxide and Why It Matters Economicall

Titanium dioxide is one of the most widely used white pigments globally, known for its ability to:

The paints and coatings sector accounts for the largest share of global consumption. The material is also used in:

3. Origin of the Legal Dispute

In 2020, the European Commission adopted the classification based on a scientific opinion issued by the European Chemicals Agency (ECHA), which concluded that inhalation of certain respirable particles of TiO₂ could pose a potential carcinogenic risk.

Accordingly, the substance was classified under “Carcinogen Category 2” (suspected carcinogen), specifically for certain powder forms.

However, several industry associations and European manufacturers challenged the decision before EU courts.

4. The Court’s Ruling

The CJEU upheld a previous judgment by the General Court annulling the classification.

The Court concluded that EU authorities had made a “manifest error of assessment” in interpreting the available scientific evidence.

While acknowledging that the General Court partially exceeded its jurisdiction by reviewing scientific methodology, the CJEU maintained the final outcome—annulment of the classification—rendering the 2020 designation invalid.

5. Scientific Counterarguments

The ruling has sparked significant debate among scientists and consumer protection organizations.

In February 2025, the Advocate General of the CJEU supported the original classification, arguing that:

Thus, the final judgment diverged from the Advocate General’s advisory opinion.

6. Regulatory Implications

1. Weakening of Hazard Classification Frameworks
The EU’s Classification, Labelling and Packaging (CLP) Regulation is a cornerstone of chemical risk management.

Such classifications typically lead to:

Experts warn that this ruling may encourage further legal challenges to future hazard classifications.

2. Implications for Nanomaterials


Civil society organizations highlighted the lack of sufficient data on nanoforms of TiO₂, which complicated scientific assessment.

This reflects a broader regulatory challenge amid the growing use of nanomaterials in global markets.

3. Strengthening Industry Influence
Consumer groups view the ruling as a victory for the chemical industry, which had strongly opposed the classification due to:

7. What Remains Unchanged

Despite the annulment, the ruling does not affect the EU ban on titanium dioxide as a food additive.

Since 2022, the EU has prohibited the use of TiO₂ (E171) in food, based on a European Food Safety Authority (EFSA) assessment that could not rule out potential genotoxic risks, and therefore could not confirm its safety for consumption.

8. Trade and Customs Implications

For Manufacturers and Exporters

For Regulators

For Customs Authorities

9. Analytical Perspective

This case highlights an ongoing tension within the EU between two key approaches:

Precautionary Approach: Advocates for preventive measures to protect public health, even under scientific uncertainty.

Evidence-Based Approach: Emphasizes the need for conclusive scientific proof before imposing regulatory restrictions that may impact industry and trade.

The ruling appears to favor legal and procedural rigor in evidence assessment over precautionary considerations.

It sets a significant legal and regulatory precedent that may influence future chemical classification decisions within the EU.

While industry stakeholders view it as a victory for scientific accuracy, consumer protection groups argue it may weaken the EU’s ability to take preventive action in safeguarding public health.

Ultimately, the case demonstrates that chemical risk management is no longer purely scientific—it is increasingly shaped by the intersection of science, law, economics, and trade.

Exit mobile version